Article
A founder noncoding GALT variant interfering with splicing causes galactosemia.
Journal of inherited metabolic disease - 1 Nov 2020
Latchman Kumarie, Brown Jeanette, Sineni Claire J, Ragin-Dames Lorrien, Guo Shengru, Huang Jingyu, Thorson Willa, Hacker Stephanie, Barbouth Deborah, Tekin Mustafa, Bademci Guney
Abstract excerpt
Galactosemia is a rare, treatable hereditary disorder of carbohydrate metabolism. We investigated the etiology of decreased GALT enzyme activity in a cohort of newborns referred by the Florida Newborn Screening Program with no detectable GALT variants in diagnostic molecular tests. Six affected individuals from four families with Guatemalan heritage were included. GALT enzyme activity ranged from 20% to 34% of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
